These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36310646)

  • 1. Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b.
    García-García T; Fernández-Rodríguez R; Redondo N; de Lucas-Rius A; Zaldívar-López S; López-Ayllón BD; Suárez-Cárdenas JM; Jiménez-Marín Á; Montoya M; Garrido JJ
    iScience; 2022 Nov; 25(11):105444. PubMed ID: 36310646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of SARS-CoV-2 accessory proteins in immune evasion.
    Zandi M; Shafaati M; Kalantar-Neyestanaki D; Pourghadamyari H; Fani M; Soltani S; Kaleji H; Abbasi S
    Biomed Pharmacother; 2022 Dec; 156():113889. PubMed ID: 36265309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.
    Redondo N; Zaldívar-López S; Garrido JJ; Montoya M
    Front Immunol; 2021; 12():708264. PubMed ID: 34305949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
    Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
    Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination of SARS-CoV-2 ORF7a Prevents Cell Death Induced by Recruiting BclXL To Activate ER Stress.
    Liu Z; Fu Y; Huang Y; Zeng F; Rao J; Xiao X; Sun X; Jin H; Li J; Yang J; Du W; Liu L
    Microbiol Spectr; 2022 Dec; 10(6):e0150922. PubMed ID: 36326498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-α-Induced Apoptosis in Cells.
    Yang R; Zhao Q; Rao J; Zeng F; Yuan S; Ji M; Sun X; Li J; Yang J; Cui J; Jin Z; Liu L; Liu Z
    Front Microbiol; 2021; 12():654709. PubMed ID: 34484133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of a SARS-CoV-2 Delta variant with an 872 nt deletion encompassing
    Mazur-Panasiuk N; Rabalski L; Gromowski T; Nowicki G; Kowalski M; Wydmanski W; Szulc P; Kosinski M; Gackowska K; Drweska-Matelska N; Grabowski J; Piotrowska-Mietelska A; Szewczyk B; Bienkowska-Szewczyk K; Swadzba J; Labaj P; Grzybek M; Pyrc K
    Euro Surveill; 2021 Sep; 26(39):. PubMed ID: 34596017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consecutive deletions in a unique Uruguayan SARS-CoV-2 lineage evidence the genetic variability potential of accessory genes.
    Panzera Y; Calleros L; Goñi N; Marandino A; Techera C; Grecco S; Ramos N; Frabasile S; Tomás G; Condon E; Cortinas MN; Ramas V; Coppola L; Sorhouet C; Mogdasy C; Chiparelli H; Arbiza J; Delfraro A; Pérez R
    PLoS One; 2022; 17(2):e0263563. PubMed ID: 35176063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression.
    Arshad N; Laurent-Rolle M; Ahmed WS; Hsu JC; Mitchell SM; Pawlak J; Sengupta D; Biswas KH; Cresswell P
    bioRxiv; 2022 May; ():. PubMed ID: 35611331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute respiratory syndrome coronavirus-2 accessory proteins ORF3a and ORF7a modulate autophagic flux and Ca
    Garrido-Huarte JL; Fita-Torró J; Viana R; Pascual-Ahuir A; Proft M
    Front Microbiol; 2023; 14():1152249. PubMed ID: 37077240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens.
    Chen Z; Ng RWY; Lui G; Ling L; Chow C; Yeung ACM; Boon SS; Wang MH; Chan KCC; Chan RWY; Hui DSC; Chan PKS
    Microbiol Spectr; 2022 Apr; 10(2):e0018222. PubMed ID: 35311586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Conservative Replacement in the Transmembrane Domain of SARS-CoV-2 ORF7a as a Putative Risk Factor in COVID-19.
    Lobiuc A; Șterbuleac D; Sturdza O; Dimian M; Covasa M
    Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14
    Zhou Z; Huang C; Zhou Z; Huang Z; Su L; Kang S; Chen X; Chen Q; He S; Rong X; Xiao F; Chen J; Chen S
    iScience; 2021 Mar; 24(3):102187. PubMed ID: 33615195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.
    Nyayanit DA; Sarkale P; Baradkar S; Patil S; Yadav PD; Shete-Aich A; Kalele K; Gawande P; Majumdar T; Jain R; Sapkal G
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):70-76. PubMed ID: 32773420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children.
    Hachim A; Gu H; Kavian O; Kwan MY; Chan WH; Yau YS; Chiu SS; Tsang OT; Hui DS; Ma F; Lau EH; Cheng SM; Poon LL; Peiris JM; Valkenburg SA; Kavian N
    medRxiv; 2021 Jan; ():. PubMed ID: 33655259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    bioRxiv; 2021 Dec; ():. PubMed ID: 34845452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of autophagy by SARS-CoV-2 proteins.
    Koepke L; Hirschenberger M; Hayn M; Kirchhoff F; Sparrer KM
    Autophagy; 2021 Sep; 17(9):2659-2661. PubMed ID: 34281462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
    Shemesh M; Aktepe TE; Deerain JM; McAuley JL; Audsley MD; David CT; Purcell DFJ; Urin V; Hartmann R; Moseley GW; Mackenzie JM; Schreiber G; Harari D
    PLoS Pathog; 2021 Aug; 17(8):e1009800. PubMed ID: 34437657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.
    Su CM; Wang L; Yoo D
    Sci Rep; 2021 Jun; 11(1):13464. PubMed ID: 34188167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.